3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
51
Fallopian Tube Neoplasms
28
Ovarian Neoplasms
23
Carcinoma, Non-Small-Cell Lung
22
Triple Negative Breast Neoplasms
15
Pancreatic Neoplasms
13
Breast Neoplasms, Male
11
Lung Neoplasms
10
Brenner Tumor
10
Inflammatory Breast Neoplasms
7
Uterine Cervical Neoplasms
5
Endometrial Adenocarcinoma
5
Adenocarcinoma of Lung
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Melanoma
4
Cholangiocarcinoma
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma, Bronchiolo-Alveolar
4
Adenocarcinoma Of Esophagus
4
Pleural Effusion, Malignant
3
Pancreatic Adenocarcinoma
3
Neoplasms
3
Thymoma
2
Neurotoxicity Syndromes
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinosarcoma
2
Breast Carcinoma In Situ
2
Interventions
Cyclophosphamide
15
romidepsin
9
Whole-Body Irradiation
9
fludarabine phosphate
8
Vincristine
8
Etoposide
8
Doxorubicin
8
Prednisone
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Brentuximab Vedotin
6
10-propargyl-10-deazaaminopterin
6
Rituximab
5
Granulocyte Colony-Stimulating Factor
5
Gemcitabine
5
Cyclosporine
5
denileukin diftitox
4
Nivolumab
4
Lenalidomide
4
mogamulizumab
3
Tacrolimus
3
Methotrexate
3
Immunohistochemistry
3
Gene Expression Profiling
3
Dexamethasone
3
Alemtuzumab
3
selinexor
2
pembrolizumab
2
pegfilgrastim
2
liposomal doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell, Peripheral
×
Taxes
×
Clear all
No trials found.